Efficacy and Safety of Anakinra in Colchicine-Resistant or -Intolerant Familial Mediterranean Fever: A Single-Center Real-Life Experience
Familial Mediterranean Fever (FMF) is characterized by recurrent febrile attacks and serositis. While colchicine is the primary treatment for FMF, some patients present resistance or intolerance with respect to this drug. Anakinra—an IL-1 receptor antagonist—has demonstrated efficacy in colchicine-r...
Saved in:
| Main Authors: | Tuğba Ocak, Havva Nur Köse, Burcu Yağız, Belkıs Nihan Coşkun, Ediz Dalkılıç, Yavuz Pehlivan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-04-01
|
| Series: | Medicina |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1648-9144/61/5/792 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Superiority of Compressed Colchicine Tablets over Coated Colchicine Tablets for Familial Mediterranean Fever
by: Mehmet Nur Kaya, et al.
Published: (2024-10-01) -
Chemotherapy-colchicine interaction in a child with Familial Mediterranean Fever and Hodgkin Lymphoma
by: Karin Petra Sabine Langenberg-Ververgaert, et al.
Published: (2018-03-01) -
Canakinumab in colchicine resistant familial Mediterranean fever and other pediatric rheumatic diseases
by: Mustafa Çakan, et al.
Published: (2020-04-01) -
Familial Mediterranean Fever: Current Approaches to Diagnosis and Treatment
by: Mikhail M. Kostik, et al.
Published: (2018-12-01) -
The needed daily dose of colchicine in patients with Familial Mediterranean Fever may be higher in women: a study on behalf of the JIR cohort
by: Ilenia Di Cola, et al.
Published: (2025-03-01)